Showing results (1-10 of 595) with videos related to
Sort By:
Pageof 60
Circulation Journal : Official Journal of the Japanese Circulation Society|March 12, 2014
Incretin therapy and heart failureJun-Ichi Oyama, Koichi NodeCardiovascular Diabetology|January 17, 2014
Do incretins improve endothelial function?Jun-Ichi Oyama, Yukihito Higashi, Koichi NodeBMJ Case Reports|November 19, 2014
Successful treatment of primary cardiac lymphoma causing ST-elevation myocardial infarction by percutaneous coronary intervention combined with chemotherapyDaisuke Nagatomo, Jun-ichi Oyama, Mari Yoshihara, et al.Cardiovascular Diabetology|November 30, 2019
GLP-1 analog liraglutide-induced cardiac dysfunction due to energetic starvation in heart failure with non-diabetic dilated cardiomyopathyAya Shiraki, Jun-Ichi Oyama, Toshiyuki Nishikido, et al.International Journal of Cardiology|August 25, 2018
A reduction of BMI predicts the risk of rehospitalization and cardiac death in non-obese patients with heart failureToshiyuki Nishikido, Jun-Ichi Oyama, Daisuke Nagatomo, et al.European Journal of Pharmacology|March 25, 2023
Linagliptin exacerbates heart failure due to energy deficiency via downregulation of glucose utilization and absorption in a mouse modelAya Shiraki, Jun-Ichi Oyama, Takahiko Shimizu, et al.Heart and Vessels|January 11, 2012
Hyperthermia by bathing in a hot spring improves cardiovascular functions and reduces the production of inflammatory cytokines in patients with chronic heart failureJun-Ichi Oyama, Yoshihiro Kudo, Toyoki Maeda, et al.Journal of Atherosclerosis and Thrombosis|February 6, 2018
Azelnidipine Inhibits the Differentiation and Activation of THP-1 Macrophages through the L-Type Calcium ChannelHiroshi Komoda, Aya Shiraki, Jun-Ichi Oyama, et al.Journal of the American Heart Association|April 6, 2016
Deletion of Apoptosis Inhibitor of Macrophage (AIM)/CD5L Attenuates the Inflammatory Response and Infarct Size in Acute Myocardial InfarctionToshiyuki Nishikido, Jun-ichi Oyama, Aya Shiraki, et al.Journal of Cardiology|July 12, 2015
High-dose statin therapy with rosuvastatin reduces small dense LDL and MDA-LDL: The Standard versus high-dose therApy with Rosuvastatin for lipiD lowering (SARD) trialToshiyuki Nishikido, Jun-Ichi Oyama, Takehiko Keida, et al.Pageof 60